编者按：淋巴瘤是最常见的血液肿瘤。数十年来，随着一系列抗体、小分子抑制剂等疗法的涌现，淋巴瘤已成为一类控制、治愈率较高的恶性肿瘤。根据临床数据，当前霍奇金淋巴瘤的治愈率已经能达到75%-80%。作为全球医药创新的赋能者，药明康德一直以来依托“一体化、 ...

A notice from an ophthalmologist in Japan, announcing a temporary closure of their clinic to attend the Nobel Prize ceremony ...

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States ...

The University of Osaka and Kyoto University have established funds to support the research fields of Nobel laureates Shimon ...

As 2025’s Nobel winners are honored this week, 2009 laureate Carol Greider reasserts the vital role of federal funding in ...

From modest beginnings, the former university president helped form the world-renowned healthcare hub into what it is today.

The vaccine advisory committee of the U.S. CDC (Centers for Disease Control and Prevention) has voted to revoke the universal recommendation requiring the vaccination of all newborns against Hepatitis ...

This year's two Japanese Nobel Prize winners spoke at separate venues in Stockholm ahead of Wednesday's Nobel Prize award ...

Stockholm, Dec. 7 (Jiji Press)--Shimon Sakaguchi, the Japanese winner of this year’s Nobel Prize in Physiology or Medicine, ...

STOCKHOLM—Japanese scientist Shimon Sakaguchi highlighted how his discoveries in immune regulation could shape the future of ...